GZMB and myeloid sarcoma: Furthermore, GzmB’s neurotoxic effects appear to transcend T cell-delivered intracellular cytotoxic mechanism in neurological diseases such as Multiple Sclerosis (MS), wherein GzmB was shown to induce neurotoxicity through interacting with the membrane bound receptors (11, 12).